The researchers also assessed the degree to which pharmacists
felt educationally prepared regarding a BTC category and the potential need for further training and/or education. The questionnaire also included 25 prescription drugs identified from pharmacist focus groups to evaluate appropriateness for inclusion in a BTC category.
Results: Pharmacists moderately agreed (5.78 +/- 1.33 [mean +/- SD]) that introducing a BTC category of medication would advance the profession’s goals of providing more pharmacist-directed patient Go 6983 inhibitor care. Pharmacists also moderately agreed (6.09 +/- 1.71) that patient counseling should be mandatory before providing any medications in a BTC category. At their current practice site, pharmacists moderately agreed (5.65 +/- 1.62)
that they would participate in providing BTC medications; however, they felt the largest issue pertaining to a BTC category of medications was the added amount of time that would be spent with patients (5.34 +/- 1.53). On the other hand, pharmacists moderately agreed (5.82 +/- 1.26) that they would take the time to counsel patients on BTC medications. Prescription prenatal vitamins (1 mg folic acid), triamcinolone cream, silver sulfadiazine cream, mometasone nasal inhalation, fluconazole 150 mg, epinephrine injection, promethazine, and mebendazole were considered the most appropriate for a BTC category of medications.
Conclusion: Ultimately, pharmacists moderately agreed that a BTC category is a change in the pharmacy profession that they were willing to embrace.”
“In this report STAT inhibitor we examined the presence of specific antibodies against equine herpesvirus type 1 (EHV-1 and equine herpesvirus type 4 (EHV-4) in several equidae, including mules, donkeys, horses. The presence of EHV-1 and EHV-4 in respiratory diseases of equids, and ability of multiplex nested polymerase chain reaction (PCR) screening in simultaneous SN-38 mw diagnosis
of horses acutely infected by EHV-1 and EHV-4 were also investigated. Sera from 504 horses, mules and donkeys sampled were tested for the presence of EHV-1 and EHV-4 specific antibodies. Blood samples taken from 21 symptomatic horses and nasal swabs taken from 40 symptomatic horses were tested for the presence of EHV-1 and EHV-4 by a multiplex nested PCR. A total of 14.3% (3/21) of buffy coat samples and 32.5% (13/40) nasal swab samples were found to contain EHV-1 DNA, while 19% (4/21) buffy coat samples and 22.5% (9/40) nasal swab samples were found to be positive for EHV-4 DNA. By species, 14.5% of horses, 37.2% of mules and 24.2% of donkeys tested were EHV-1 seropositive. EHV-4 specific antibodies were detected in 237 (81.7%) of 290 horse sera tested. Results from this investigation demonstrate that EHV-1 and EHV-4 are prevalent throughout the equid population, and that donkeys and mules might also represent an important source of infection for other equids.